Clinical trial
Oral Capsule-administered Faecal Microbiota Transplantation for Intestinal Carbapenemase-producing Enterobacteriaceae Decolonization
NCT04746222 is registered in ClinicalTrials.gov with Tan Tock Seng Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oral Capsule-administered Faecal Microbiota Transplantation for Intestinal Carbapenemase-producing Enterobacteriaceae Decolonization
- Lead sponsor
- Tan Tock Seng Hospital
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- July 31, 2021
- Completion date
- July 31, 2023
- Enrollment
- 108 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
carbapenem-resistant enterobacteriaceae infection